Skip to content

Homoeopathic medicines for neck pain

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines as adjunctive to concomitant care in managing chronic neck pain in adolescents and adults

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051991
Enrollment
74
Registered
2023-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M542- Cervicalgia

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies with concomitant care: Intervention is planned as administering the indicated homeopathic medicines in centesimal potencies
dosage and repetition will be maintained depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. All the part

Sponsors

The Calcutta Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from chronic neck pain for 3 months or more. 2. Age between 10 and 65 years 3. Patients of either sex, including transgender 4. Literate patients; ability to read English, Bengali or Hindi and illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires 5. Willing to take part in the study and give written informed assent and/or consent voluntarily

Exclusion criteria

Exclusion criteria: 1. Patients with known cervical radiculopathy (using spurling test) or having any severe pathological conditions causing neck pain. (e.g., cervical spondylosis, kyphosis, scoliosis, history of spinal injury, disc prolapse etc.) 2. Patients suffering from autoimmune disorders that impacts the musculoskeletal system (e.g., lupus, rheumatoid arthritis, ankylosing spondylitis) 3. Patients who are undergoing treatment with NSAIDs during 6 weeks prior to enrolment in the study. 4. Patients having history of any degenerative muscular or neurological condition that can impact the outcome measure (e.g., Parkinsonâ??s disease, amyotrophic lateral sclerosis, multiple sclerosis, different myelopathy, muscular dystrophy, etc.) 5. Patients taking spinal corticosteroid injection within 6 months. 6. Patients suffering from active or chronic, systemic, or local infection or disease. 7. The chronic neck pain is due to any invasive malignant disease/neoplasia. 8. Vulnerable population - unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, institutionalized persons, mentally disabled people. 9. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness or serious illness (like cardiac disease) affecting the quality of life or organ failure. 10. Pregnant and postpartum women, lactation. 11. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other forms of substance abuse and/or dependence. 12. Self-reported immune-compromised condition. 13. Already been in homeopathic treatment for any chronic illness for the last 6 months. 14. Simultaneous participation in any other clinical trial

Design outcomes

Secondary

MeasureTime frame
EQ-5D-5L questionnaireTimepoint: At baseline, every month, up to 3 months;EQ-5D-5L VASTimepoint: At baseline, every month, up to 3 months

Primary

MeasureTime frame
Pain Detect Questionnaire (PDQ)Timepoint: At baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactRajat Chattopadhyay

The Calcutta Homoeopathic Medical College and Hospital

dr.rajatchatterjee@gmail.com9331041142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026